An intraocular lens (IOL) is an advanced option for patients to improve their vision without heavy dependence on glasses and… Read More
Millions of people in America, particularly those over the age of 40, are affected by presbyopia and other conditions associated with aging eyes. Presbyopia is characterized by a gradual loss of visual acuity when looking at objects up close, and has traditionally resulted in the need for bifocals or trifocals for many individuals. The condition is often part of what’s known as Dysfunctional Lens Syndrome, which causes the progressive decline of the eye’s natural lens to focus clearly on objects. The good news is, doctors at Gordon Schanzlin New Vision Institute offer an array of treatment options that can improve symptoms of presbyopia and aging eye conditions to reduce reliance on corrective eyewear. Our experienced ophthalmologists have also participated in clinical trials, such as the recently FDA approved KAMRA™ inlay, which have examined new and innovative procedures that can potentially treat aging eye conditions and help patients see with a much clearer view.
To learn more about aging eye conditions and our advanced treatment options, please contact us today.
The crystalline lens of the eye is what allows us to focus on up-close objects. Its flexibility helps the eye to rapidly adjust focus between objects that are far away and those that are near. As we age, the eye’s crystalline lens begins to lose its elasticity, making it progressively more difficult for the eyes to maintain clear focus between far and near objects. This loss of elasticity is ultimately what causes presbyopia. Symptoms of the condition include:
Unfortunately, presbyopia typically does not cause any overt symptoms until years after the condition has already begun to affect the eyes; however, presbyopia can be diagnosed with a simple eye exam. This makes it very important, particularly for patients aged 40 and over, to have a comprehensive eye evaluation at least once each year.
Please take a look at our website devoted to presbyopia and aging eye conditions for more information on this condition.
Dysfunctional Lens Syndrome, or DLS, is a term often used to describe a decline in vision due a gradual loss of flexibility in the eye’s natural lens. DLS is a very common condition, and will happen to most people as they get older. The first stage of DLS typically begins in one’s 40s, often leading to the need for bifocals or reading glasses. The second stage frequently occurs in the 50s to 60s age range, and generally involves a degradation of lens optics. This can result in yellowing vision, a light-scattering effect, problems seeing clearly at night, and the need for extra light while reading. By the time individuals reach their 70s, the third stage of DLS often presents itself. This stage typically involves the formation of a cataract.
Fortunately, there are a variety of state-of-the-art treatment options available here at Gordon Schanzlin New Vision Institute that can address the symptoms of DLS and offer you long-term vision improvement.
Many cases of presbyopia and other aging vision conditions are treatable with advanced procedures designed to limit the need for bifocals or other types of corrective eyewear. During your initial consultation, our ophthalmologist will talk with you about your options and determine which would be best for your needs and goals. Treatments for presbyopia include
Monovision LASIK or PRK are laser treatments that can correct one eye for far-distance vision and the other eye for near-distance vision. The brain can then blend these images together for the clearest results possible.
Intraocular lenses (IOLs) can also be used for this purpose; however, IOL procedures require the removal of the eye’s natural lens and replacement with the IOL, and therefore this procedure is not reversible.
Of course, there is always corrective eyewear such as reading glasses or bifocals/trifocals that can help patients with presbyopia. Our ophthalmologist will listen to all of your concerns and discuss the best possible treatment options for your needs.
Learn more about treatments for presbyopia on our companion website.
Gordon Schanzlin New Vision Institute was one of the original clinical investigators for a U.S. Food and Drug Administration study on the The KAMRA™ corneal inlay. This innovative treatment recently received FDA approval to treat the loss of near vision that is often associated with presbyopia. The KAMRA™ inlay can provide a natural range of vision from near to far distances without zones of blurriness. This treatment can not only reduce reliance on reading glasses, it can also help patients maintain clear near vision even as presbyopia progresses.
The KAMRA™ inlay essentially acts like a pinhole allowing light to move from the front to the back of the eye, expanding your natural range of vision. The microscopically small corneal inlay is carefully placed inside the cornea of only one eye, which can enable you to see near objects more clearly while retaining distance vision in both of your eyes. This ultimately helps the eyes work together to clearly see both near and far distances.
The FDA has approved the KAMRA™ inlay for patients diagnosed with presbyopia who are between the ages of 45 and 60 and who have prescriptions of +0.50 D to -0.75 D, with a near correction of +1.00 D to +2.50 D for reading. One of the many benefits associated with the KAMRA™ inlay procedure is that it is reversible – if you are not completely happy with the results, the inlay can be removed.
Our doctors here at Gordon Schanzlin New Vision Institute will give you a comprehensive eye exam and help you determine if this advanced new treatment for presbyopia is right for your needs.
If you would like more information on presbyopia and the treatment options available at Gordon Schanzlin New Vision Institute, or if you would like to schedule a consultation, please contact us today.